Austrália - inglês - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -

Estados Unidos - inglês - NLM (National Library of Medicine)

synthon pharmaceuticals, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - tablet - 2.5 mg - amlodipine besylate is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. amlodipine besylate is indicated for the treatment of chronic stable angina. amlodipine besylate may be used alone or in combination with other antianginal agents. amlodipine besylate is indicated for the treatment of confirmed or suspected vasospastic angina. amlodipine besylate may be used as monotherapy or in combination with other antianginal drugs. amlodipine besylate is contraindicated in patients with known sensitivity to amlodipine.

Estados Unidos - inglês - NLM (National Library of Medicine)

china resources saike pharmaceutical co., ltd. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 5 mg - amlodipine is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechani

Estados Unidos - inglês - NLM (National Library of Medicine)

par pharmaceutical - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic

Estados Unidos - inglês - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pha

Canadá - inglês - Health Canada

apotex inc - amlodipine (amlodipine besylate) - tablet - 5mg - amlodipine (amlodipine besylate) 5mg - dihydropyridines

Canadá - inglês - Health Canada

auro pharma inc - amlodipine (amlodipine besylate) - tablet - 5mg - amlodipine (amlodipine besylate) 5mg - dihydropyridines

Canadá - inglês - Health Canada

jamp pharma corporation - amlodipine (amlodipine besylate) - tablet - 5mg - amlodipine (amlodipine besylate) 5mg - dihydropyridines

Canadá - inglês - Health Canada

jubilant generics limited - amlodipine (amlodipine besylate) - tablet - 5mg - amlodipine (amlodipine besylate) 5mg - dihydropyridines

Canadá - inglês - Health Canada

actavis pharma company - amlodipine (amlodipine besylate) - tablet - 5mg - amlodipine (amlodipine besylate) 5mg - dihydropyridines